1. Home
  2. QTTB vs GSIW Comparison

QTTB vs GSIW Comparison

Compare QTTB & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$3.20

Market Cap

25.1M

Sector

Health Care

ML Signal

HOLD

GSIW

Garden Stage Limited

HOLD

Current Price

$0.13

Market Cap

28.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTTB
GSIW
Founded
2015
2016
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.1M
28.6M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
QTTB
GSIW
Price
$3.20
$0.13
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$7.33
N/A
AVG Volume (30 Days)
9.1M
314.5K
Earning Date
11-13-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,368,221.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
283.23
52 Week Low
$1.35
$0.09
52 Week High
$6.37
$1.79

Technical Indicators

Market Signals
Indicator
QTTB
GSIW
Relative Strength Index (RSI) 56.78 39.19
Support Level $2.92 $0.13
Resistance Level $3.96 $0.14
Average True Range (ATR) 0.30 0.01
MACD -0.02 -0.00
Stochastic Oscillator 51.07 12.65

Price Performance

Historical Comparison
QTTB
GSIW

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

Share on Social Networks: